Magazine Article | May 9, 2017

Pharma Embraces The Cloud ... Cautiously

Source: Life Science Leader

By Gail Dutton, Contributing Editor
Follow Me On Twitter @GailLdutton

Pharmaceutical companies that have, until recently, eschewed cloud computing are migrating applications into that environment. Adoption began gradually, first with functions that aren’t mission-critical. After a few years’ experience, they’re still cautious, seeking to adopt the cloud strategically while minimizing risks.

Santen, a Japanese pharmaceutical company specializing in ophthalmology, uses the cloud-based SAS data analytics platform to collaborate with its global team of programmers, statisticians, and scientists. “We wanted a centralized location for all our data from all of our sites,” says Nina Worden, director of statistical programming at Santen.